Reprogramming symbiotic bacteria from the human microbiome to administer medicines directly to the organs they naturally inhabit

Tenza specializes in the innovative use of probiotic microbes, transforming them into living factories that produce and deliver pharmaceuticals directly to the body. This approach aims to enhance the potency, reduce the pain associated with drug delivery, and lower costs compared to traditional pharmaceutical methods. By leveraging the natural capabilities of these microbes, Tenza seeks to revolutionize how medications are administered and absorbed, potentially improving patient outcomes and overall treatment experiences.

The company's pipeline and product offerings are centered around this unique technology, which harnesses the power of probiotics to create a more efficient and effective means of drug delivery. Tenza's focus on utilizing living organisms for therapeutic purposes represents a significant advancement in the field of medicine, promising to address various health challenges with a novel and biologically integrated approach. This innovative strategy not only aims to improve the efficacy of treatments but also to make them more accessible and manageable for patients.

United States

Tenza reprograms symbiotic bacteria from the human microbiome to administer medicines directly to the organs they naturally inhabit.

Tenza

Company Details